Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effects of SARS-CoV-2 Infection on Attention, Memory, and Sensorimotor Performance

View ORCID ProfileErin E. O’Connor, Nikita Rednam, Rory O’Brien, Shea O’Brien, Peter Rock, Andrea Levine, View ORCID ProfileThomas A. Zeffiro
doi: https://doi.org/10.1101/2022.09.22.22280222
Erin E. O’Connor
1University of Maryland School of Medicine, Department of Diagnostic Radiology & Nuclear Medicine, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erin E. O’Connor
  • For correspondence: erin.oconnor@umm.edu thomas.zeffiro@som.umaryland.edu
Nikita Rednam
1University of Maryland School of Medicine, Department of Diagnostic Radiology & Nuclear Medicine, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rory O’Brien
2Lantern Lab, Fulton, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shea O’Brien
2Lantern Lab, Fulton, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rock
3University of Maryland School of Medicine, Department of Anesthesiology, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Levine
4University of Maryland School of Medicine, Department of Internal Medicine, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Zeffiro
1University of Maryland School of Medicine, Department of Diagnostic Radiology & Nuclear Medicine, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas A. Zeffiro
  • For correspondence: erin.oconnor@umm.edu thomas.zeffiro@som.umaryland.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Recovery after SARS-CoV-2 infection is extremely variable, with some individuals recovering quickly, and others experiencing persistent long-term symptoms or developing new symptoms after the acute phase of infection, including fatigue, poor concentration, impaired attention, or memory deficits. Many existing studies reporting cognitive deficits associated with SARS-CoV-2 infection are limited by the exclusive use of self-reported measures or a lack of adequate comparison groups.

Methods Forty-five participants, ages 18-70, (11 Long-COVID, 14 COVID, and 20 No-COVID) underwent behavioral testing with the NIH Toolbox Neuro-Quality of Life survey and selected psychometric tests, including a flanker interference task and the d2 Test of Attention.

Results We found greater self-reported anxiety, apathy, fatigue, emotional dyscontrol, sleep disturbance and cognitive dysfunction in COVID compared No-COVID groups. After categorizing COVID patients according to self-reported concentration problems, we observed declining performance patterns in multiple attention measures across No-COVID controls, COVID and Long-COVID groups. COVID participants, compared to No-COVID controls, exhibited worse performance on NIH Toolbox assessments, including the Eriksen Flanker, Nine-Hole Pegboard and Auditory Verbal Learning tests.

Conclusion This study provides convergent evidence that previous SARS-CoV-2 infection is associated with impairments in sustained attention, processing speed, self-reported fatigue and concentration. The finding that some patients have cognitive and visuomotor dysfunction in the absence of self-reported problems suggests that SARS-CoV-2 infection can have unexpected and persistent subclinical consequences.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the University of Maryland Baltimore, Institute for Clinical & Translational Research and the National Center for Advancing Translational Sciences (NCATS) CTSA grant number 1UL1TR003098

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study procedures were approved by the Institutional Review Board at University of Maryland School of Medicine and all participants provided written informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Study funding: University of Maryland Baltimore, Institute for Clinical & Translational Research and the National Center for Advancing Translational Sciences (NCATS) CTSA grant number 1UL1TR003098

  • Disclosures:

  • Dr. O’Connor reports no disclosures.

  • Ms. Rednam reports no disclosures.

  • Mr. O’Brien reports no disclosures.

  • Ms. O’Brien reports no disclosure.

  • Dr. Rock reports no disclosures.

  • Dr. Levine reports no disclosures

  • Dr. Zeffiro reports no disclosures.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 23, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effects of SARS-CoV-2 Infection on Attention, Memory, and Sensorimotor Performance
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effects of SARS-CoV-2 Infection on Attention, Memory, and Sensorimotor Performance
Erin E. O’Connor, Nikita Rednam, Rory O’Brien, Shea O’Brien, Peter Rock, Andrea Levine, Thomas A. Zeffiro
medRxiv 2022.09.22.22280222; doi: https://doi.org/10.1101/2022.09.22.22280222
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effects of SARS-CoV-2 Infection on Attention, Memory, and Sensorimotor Performance
Erin E. O’Connor, Nikita Rednam, Rory O’Brien, Shea O’Brien, Peter Rock, Andrea Levine, Thomas A. Zeffiro
medRxiv 2022.09.22.22280222; doi: https://doi.org/10.1101/2022.09.22.22280222

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (240)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1419)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (584)
  • Epidemiology (10293)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2629)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1731)
  • Health Policy (789)
  • Health Systems and Quality Improvement (672)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12090)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (289)
  • Neurology (2460)
  • Nursing (145)
  • Nutrition (377)
  • Obstetrics and Gynecology (492)
  • Occupational and Environmental Health (567)
  • Oncology (1321)
  • Ophthalmology (401)
  • Orthopedics (146)
  • Otolaryngology (236)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (780)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2397)
  • Public and Global Health (5002)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (525)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (245)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)